License partnerships
We collaborate with leading MedTech companies that apply the technology to their medical devices and sell them under their own brand or co-branded with Bactiguard.
Our partnerships are more than a business alliance; they are a joint mission to protect more patients and make a substantial impact in the medical world.
A vision to become the global standard of care
At Bactiguard, we are driven by a vision far beyond business success – we are committed to becoming the global standard of care in infection control, because we believe the best way to protect against infections is to prevent them.
Our goal is clear: to make our innovative infection control solutions universally available, setting a new benchmark for medical device safety and efficacy.
By integrating Bactiguard’s coating technology, your MedTech company can be at the forefront of this transformative journey, making a profound impact on global healthcare.
Enhance your medical devices with advanced infection control
Bactiguard’s coating technology offers a comprehensive solution for MedTech companies seeking to differentiate themselves from competition and enhance the performance and success of their medical devices. A Bactiguard coated surface prevents primary adhesion as fewer bacteria attach to the surface, reducing the risk of biofilm formation and subsequent infections.
By reducing the risk of device-related infection, it ensures more consistent treatment outcomes and fewer complications.
This facilitates faster patient recovery and ultimately leads to improved clinical results; a compelling reason to choose your product over the competitor’s. Our coating technology is adaptable to any application area where it is important to reduce the risk of infections.
Support in bringing Bactiguard coated devices to the market
Bactiguard provides license partners not only with coating technology but also application know-how, for instance through setting up manufacturing production lines. Providing clinical expertise, sales and marketing support, coupled with comprehensive training on our technology’s functionality and value, we ensure that our partners are well-equipped to effectively market and sell their Bactiguard coated products. This includes engaging with healthcare professionals and other stakeholders within the healthcare system.
We support our partners by:
- Technology and know-how
- Regulatory guidance and expertise
- Sales and marketing support and training
- Medical and clinical expertise
License partners
Bactiguard has had a successful license partnership with CR Bard, now BD (Becton Dickinson and Company), one of the market leaders within the urology therapeutic area.
Bactiguard has one partnership with Zimmer Biomet. The first is a licensing partnership related to orthopedic trauma implants for which Bactiguard received a CE mark for the coated version in 2021.
Well Lead Medical, China’s leading manufacturer of consumable medical devices, has since 2018 the exclusive right to market and sell Bactiguard coated Foley catheters in China.
| Licensee | Start year | Geographic market | Products |
|---|---|---|---|
| Becton, Dickinson and Company (BD) | 1990 | Exclusive global license partner excluding China | Urinary catheter Bardex IC and Lubrisil IC |
| Well Lead Medical | 2018 | China | Well Lead Medical is currently at the approval process stage to enable it to sell locally-produced catheters and tubes. |
| Zimmer Biomet | 2019 | Global agreement excluding South-East Asia, China, India and South Korea | Orthopedic trauma implants |
Manufacturing
The partner journey
